Supenya Varothai1, Wilma F Bergfeld. 1. Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Abstract
BACKGROUND: Androgenetic alopecia (AGA) is one of the most common chronic problems seen by dermatologists worldwide. It is characterized by progressive hair loss, especially of scalp hair, and has distinctive patterns of loss in women versus men, but in both genders the central scalp is most severely affected. It often begins around puberty and is known to effect self-esteem and the individual's quality of life. In contrast to the high prevalence of AGA, approved therapeutic options are limited. In addition to the scarce pharmacologic treatments, there are numerous nonprescription products claimed to be effective in restoring hair in androgenetic alopecia. OBJECTIVES: The purpose of this paper is to review published medical and non-medical treatments for male and female AGA using the American College of Physicians evidence assessment methods. MEDLINE, EMBASE and Cochrane Library were searched for systematic reviews, randomized controlled trials, open studies, case reports and relevant studies of the treatment of male and female AGA. The relevant articles were classified according to grade and level of evidence. RESULTS: The medical treatments with the best level of evidence classification for efficacy and safety for male AGA are oral finasteride and topical minoxidil solution. For female AGA, topical minoxidil solution appears to be the most effective and safe treatment. The medical treatments corresponding to the next level of evidence quality are some commonly used therapeutic non-FDA-approved options including oral and topical anti-hormonal treatments. Surgical treatment of follicular unit hair transplantation is an option in cases that have failed medical treatment although there is high variation in outcomes. LIMITATIONS: Some articles, especially those concerning traditional herbs claimed to promote hair regrowth, were published in non-English, local journals. CONCLUSIONS: An assessment of the evidence quality of current publications indicates that oral finasteride (for men only) and topical minoxidil (for men and women) are the best treatments of AGA.
BACKGROUND: Androgenetic alopecia (AGA) is one of the most common chronic problems seen by dermatologists worldwide. It is characterized by progressive hair loss, especially of scalp hair, and has distinctive patterns of loss in women versus men, but in both genders the central scalp is most severely affected. It often begins around puberty and is known to effect self-esteem and the individual's quality of life. In contrast to the high prevalence of AGA, approved therapeutic options are limited. In addition to the scarce pharmacologic treatments, there are numerous nonprescription products claimed to be effective in restoring hair in androgenetic alopecia. OBJECTIVES: The purpose of this paper is to review published medical and non-medical treatments for male and female AGA using the American College of Physicians evidence assessment methods. MEDLINE, EMBASE and Cochrane Library were searched for systematic reviews, randomized controlled trials, open studies, case reports and relevant studies of the treatment of male and female AGA. The relevant articles were classified according to grade and level of evidence. RESULTS: The medical treatments with the best level of evidence classification for efficacy and safety for male AGA are oral finasteride and topical minoxidil solution. For female AGA, topical minoxidil solution appears to be the most effective and safe treatment. The medical treatments corresponding to the next level of evidence quality are some commonly used therapeutic non-FDA-approved options including oral and topical anti-hormonal treatments. Surgical treatment of follicular unit hair transplantation is an option in cases that have failed medical treatment although there is high variation in outcomes. LIMITATIONS: Some articles, especially those concerning traditional herbs claimed to promote hair regrowth, were published in non-English, local journals. CONCLUSIONS: An assessment of the evidence quality of current publications indicates that oral finasteride (for men only) and topical minoxidil (for men and women) are the best treatments of AGA.
Authors: Marina Perper; Adam S Aldahan; Rachel A Fayne; Christopher P Emerson; Keyvan Nouri Journal: Lasers Med Sci Date: 2017-08-16 Impact factor: 3.161
Authors: Ion G Motofei; David L Rowland; Mirela Manea; Simona R Georgescu; Ioana Păunică; Ioanel Sinescu Journal: Clin Drug Investig Date: 2017-06 Impact factor: 2.859
Authors: Dong Hyuk Eun; Seok Min Kim; Yong Hyun Jang; Seok-Jong Lee; Do Won Kim; Weon Ju Lee Journal: Ann Dermatol Date: 2017-12-26 Impact factor: 1.444
Authors: P A Boland; M E Kelly; N E Donlon; J C Bolger; J O Larkin; B J Mehigan; P H McCormick Journal: Int J Colorectal Dis Date: 2020-07-25 Impact factor: 2.571
Authors: Shahenur Alam Sakib; Abu Montakim Tareq; Ameerul Islam; Ahmed Rakib; Mohammad Nazmul Islam; Mohammad Arafat Uddin; Md Masudur Rahman; Veronique Seidel; Talha Bin Emran Journal: Plants (Basel) Date: 2021-05-27